Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Manchester cake-maker becomes internet sensation after her Star Wars creation.
Cloudy skies, spells of rain and strong gusty winds continue across the northwest over the next few days
A woman has been banned from keeping animals for life after her dog was found in such a bad state of health that he had to be put to down.